dZinc supplements are an effective clinical treatment for infantile diarrheal disease caused by enteric pathogens. Previous studies demonstrated that zinc acts on enteropathogenic Escherichia coli (EPEC) bacteria directly to suppress several virulence-related genes at a concentration that can be achieved by oral delivery of dietary zinc supplements. Our in vitro studies showed that a micromolar concentration of zinc induced the envelope stress response and suppressed virulence in EPEC, providing a possible mechanistic explanation for zinc's therapeutic action. In this report, we investigated the molecular and physiological changes in EPEC induced by zinc. We found that micromolar concentrations of zinc reduced the bacterial growth rate without affecting viability. We observed increased membrane permeability caused by zinc. Zinc upregulated the RpoE-dependent envelope stress response pathway and suppressed EPEC virulence gene expression. RpoE alone was sufficient to inhibit virulence factor expression and to attenuate attaching and effacing lesion formation on human host cells. By mutational analysis we demonstrate that the DNA-binding motif of RpoE is necessary for suppression of the LEE1, but not the LEE4, operon. Predictably, inhibition of the RpoE-mediated envelope stress response in combination with micromolar concentrations of zinc reduced EPEC viability. In conclusion, zinc induces the RpoE and stress response pathways in EPEC, and the alternate sigma factor RpoE downregulates EPEC LEE and non-LEE virulence genes by multiple mechanisms.A cute diarrheal infections (ADI) are a major cause of morbidity and mortality in children, particularly those living in developing countries. Worldwide, children suffer from ϳ2 billion bouts of diarrhea annually, with approximately 1 million children under the age of 5 years dying of ADI every year. Even nonlethal infections can lead to malnutrition, cognitive impairment, and permanent gastrointestinal damage.In 2008, the World Health Organization began administering dietary zinc supplements with oral rehydration therapy to those suffering from ADI. Along with restoring normal zinc levels, which are essential for proper immune function (1, 2), this metal ion affects the virulence of gastrointestinal, bacterial pathogens even in children with normal plasma zinc concentrations. In 1995, a double-blind, randomized control trial involving 937 children with acute diarrhea in New Delhi, India, demonstrated that dietary zinc supplements of 20 mg per day given to children under the age of 3 years significantly reduced the severity and duration of disease (3). The children were 23% less likely to have continued diarrhea, with a 39% reduction in the frequency of episodes. There was a 21% reduction in the mean number of days with watery stools and a 39% drop in the number of watery stools per day. Thus, by a yet unknown mechanism, zinc dietary supplements benefited children with ADI, even those with normal plasma zinc levels.To understand the mechanism by which zinc affected bacterium...